Physician profile
Friday G Simpson
NPI 1851503411
$3,030.88
in general payments reported to CMS, 2019-2025
14 companies · $372 in 2025
The $372 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $175 · 2021: $583 · 2022: $644 · 2023: $438 · 2024: $552 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,362.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,177.60 | 2021-2024 | Vraylar |
| Novo Nordisk INC | $449.05 | 2019-2024 | Wegovy |
| Jazz Pharmaceuticals INC. | $396.00 | 2020-2025 | |
| Axsome Therapeutics, INC. | $248.04 | 2024-2025 | Sunosi |
| Amgen INC. | $179.76 | 2022 | |
| Pfizer INC. | $137.94 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $124.06 | 2023 | Rexulti |
| Allergan, INC. | $110.34 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $107.00 | 2025 | Austedo Xr |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.46 | 2020-2021 | |
| Lilly USA, LLC | $24.86 | 2024 | Mounjaro |
| Shire North American Group INC | $13.55 | 2019 | |
| Redhill Biopharma INC. | $12.53 | 2021 | |
| Kvk-Tech, INC. | $10.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Friday Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.